El Coronado Holdings, LLC
CIK 1319763 · last filed 2014-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CHTP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
DALLAS, TX 75204
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Chelsea Therapeutics International, Ltd. (CHTP) Delisted | 10%+ Owner | 6,871,981 | — | — | $22.59M | 54 | 2012-12-19 |
| NOVOGEN LTD (NVGN) Delisted | 10%+ Owner | 4,064,611 | — | — | $25.24M | 28 | 2008-07-31 |
Recent Filings · Page 5 of 9
89 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-04-18 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Buy (P) | +16,520 | $75.7K | EDGAR |
| 2008-04-11 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Buy (P) | +4,000 | $19.1K | EDGAR |
| 2008-04-09 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Buy (P) | +6,000 | $29.1K | EDGAR |
| 2008-04-07 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Buy (P) | +2,000 | $9.7K | EDGAR |
| 2008-03-31 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Buy (P) | +10,000 | $52.8K | EDGAR |
| 2008-03-27 | NOVOGEN LTD (NVGN) Delisted | Buy (P) | +14,000 | $68.6K | EDGAR |
| 2007-11-16 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Buy (P) | +21,998 | $134.5K | EDGAR |
| 2007-11-13 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Buy (P) | +495,770 | $3.28M | EDGAR |
| 2007-09-11 | NOVOGEN LTD (NVGN) Delisted | Buy (P) | +870,078 | $6.75M | EDGAR |
| 2007-08-24 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Buy (P) | +37,600 | $203.3K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.